NEW YORK (GenomeWeb News) – German analytical instrument firm Analytik Jena today announced it signed a contract to acquire life science imaging company UVP for an undisclosed price.

The deal is anticipated to close April 5, and, in addition to acquiring UVP, Analytik Jena will purchase the Upland, Calif.-based company's wholly owned subsidiary Ultra-Violet Products, headquartered in Cambridge, UK.

The deal launches Analytik Jena into the US market, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.